Abiomed’s Post

Left ACA infarction. Occlusive stenosis is observed in ACA. Reperfusion was achieved with Credo 3-20 stent.

When executing #qPCRresearch, it’s important to make sure your dyes play well together. #qPCRmultiplexing offers many advantages including more data per well and higher throughput. If you are designing a multiplex assay for #infectiousdiseaseresearch (or any other application), try our free, updated, easily customizable online tool to make sure your dyes are compatible: https://idtb.io/pj5bqn #qPCR #multiplexing #qPCRprobes

To leave in place or not the Impella after a high-risk percutaneous coronary intervention is a tough decision. The latest PROTECT III sub-analysis gives some insight (DOI: 10.4244/EIJ-D-23-00512) that We had the chance to discuss in an Editorial with alaide chieffo. EuroIntervention. 2024 Jan 15;20(2):e113-e114 #PROTECTPCI #HIGHRISKPCI #IMPELLA #MECHANICALSUPPORT

LloydsPharmacy Online Doctor announces partnership with Preventx to boost STI testing service Read more-LloydsPharmacy Online Doctor joins hands with Preventx to boost STI testing service #LloydsPharmacyPartnership #OnlineDoctorCollaboration #PreventxSTITesting #DigitalHealthAlliance

High performance & low Reagent consumption

This review highlights advances in the structure, function, and regulation of membrane adenylyl cyclases, which are vital for signal transduction yet poorly understood. Did you know that we work hard to bring you the most recent GPCR News, weekly? Catch up today in the Ecosystem using your free site membership! ➡️https://bit.ly/49DWJOb #gpcr #drgpcr

Thanks to #BCIS for organising another great #BCISACI meeting. Two main points I’ve taken away from the meeting: 1) DCB/ DEB balloons are your friend. Minimise metal if possible/ appropriate. Caveat being that there are trials currently recruiting. Guidelines are driven by trial data and it may take some time for this to happen, but there’s certainly a growing body of evidence, expertise and interest. 2) CTCA and #HeartFlow analysis are changing the game. Slowly, but surely. If you have access to it, use it to your advantage and help plan your PCI and make your cath lists more effecient and exciting. Nobody likes a diagnostic list. Caveat: It’s only as good as the images you acquire, therefore a) scanner, b) patient selection and c) patient prep are key.

The phase 3 PACIFIC-2 trial did not meet its primary end point of PFS compared with CRT alone in the treatment of unresectable, stage III #NSCLC. #lcsm https://lnkd.in/eRZjJj5b

There is a lot of hype now around drug-coated balloon, including its use in #complexPCI and #CTOpci. We have done #DCBonly in #CTOpci since 2012 in our institution. The first case was an 80yrs old patient at high bleeding risk (OAC). The RCA CTO was antegradely wired with CP12 and predilated with a 3.5mm balloon. Two #Sequentplease DCBs (3.5x30mm) were used. Only one-month SINGLE antiplatelet treatment was prescribed (clopidogrel). Control angio 2 years later showed nice positive vessel remodeling. The other case shown here was a 55yrs old patient on OAC. The RCA CTO was antegradely wired with Pilot150 and predilated with a 3.0mm balloon. Three #Sequentplease DCBs (one 3.0x33mm and two 2.75x26mm) were used. The patient had angio 8 yrs later showing an excellent long-term result. In our experience the #leavingnothingbehind approach is a good option in #CTOpci after intraplaque wiring in case the lesion does not need mechanical support but just the antiproliferative drug. Especially, long lesions, diffuse disease, bifurcations and high bleeding risk patients are intriguing targets for #DCBonly PCI. #siunsote #uef